Pharmaceutical giants are raking in billions selling doses to the richest countries, while Sub-Saharan Africa is struggling to save its people.
Will It Be a Blue Wave?
With limited data, exactly how many Republican incumbents are in trouble is hard to know. But Democrats have good reason to think big.
Keep reading
by Bill Scher

